β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study

Abstract Background Long term β-blocker therapy after myocardial infarction (MI) reduces mortality and recurrent MI but evidence for this treatment predates contemporary acute coronary care. β-blocker treatment is a key quality of care indicator in the Swedish national quality register for acute cor...

Full description

Bibliographic Details
Main Authors: Tora Hagsund, Sven-Erik Olsson, J. Gustav Smith, Bjarne Madsen Hardig, Henrik Wagner
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12872-020-01441-0